Significant reductions in body weight are observed with 3.0 mg and 4.5 mg dulaglutide, doses which have been recently approved for people living with T2DM who are taking metformin but experiencing inadequate glycemic control [66, 119]
(A placebo is a substance that has no effect and is used as a control when testing medications)
Commonly Reported Side Effects Based on community reports, side effects appear relatively uncommon and typically mild: Most Frequently Reported: Injection site reactions (redness, minor pain, itching) Mild nausea (particularly with oral administration) Temporary dizziness Headache Fatigue Less Commonly Reported: Skin flushing Changes in appetite Temporary mood changes Vivid dreams Theoretical Concerns Growth Factor Effects: BPC-157's upregulation of growth factors raises theoretical concerns for: Cancer promotion in those with existing malignancies Acceleration of undiagnosed tumors Effects on benign growths (polyps, fibroids) No evidence directly supports these concerns, but caution is warranted given the mechanisms involved
Gluta One Niacinamide Serum (Evening) Strengthens the skin barrier, reduces dark spots, and controls excess pigmentation
[4] The peptide survives digestion long enough to act on the mucosa, but clears too rapidly to accumulate in systemic circulation
